purchase customization

1 Study Coverage
1.1 Active Transdermal Drug Delivery Device Product Introduction
1.2 Global Active Transdermal Drug Delivery Device Outlook 2017 VS 2022 VS 2028
1.2.1 Global Active Transdermal Drug Delivery Device Sales in US$ Million for the Year 2017-2028
1.2.2 Global Active Transdermal Drug Delivery Device Sales in Volume for the Year 2017-2028
1.3 United States Active Transdermal Drug Delivery Device Outlook 2017 VS 2022 VS 2028
1.3.1 United States Active Transdermal Drug Delivery Device Sales in US$ Million for the Year 2017-2028
1.3.2 United States Active Transdermal Drug Delivery Device Sales in Volume for the Year 2017-2028
1.4 Active Transdermal Drug Delivery Device Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Active Transdermal Drug Delivery Device in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Active Transdermal Drug Delivery Device Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Active Transdermal Drug Delivery Device Market Dynamics
1.5.1 Active Transdermal Drug Delivery Device Industry Trends
1.5.2 Active Transdermal Drug Delivery Device Market Drivers
1.5.3 Active Transdermal Drug Delivery Device Market Challenges
1.5.4 Active Transdermal Drug Delivery Device Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Active Transdermal Drug Delivery Device Market Segment by Type
2.1.1 Patches
2.1.2 Gels
2.2 Global Active Transdermal Drug Delivery Device Market Size by Type
2.2.1 Global Active Transdermal Drug Delivery Device Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Active Transdermal Drug Delivery Device Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Active Transdermal Drug Delivery Device Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Active Transdermal Drug Delivery Device Market Size by Type
2.3.1 United States Active Transdermal Drug Delivery Device Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Active Transdermal Drug Delivery Device Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Active Transdermal Drug Delivery Device Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Active Transdermal Drug Delivery Device Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Home Use
3.2 Global Active Transdermal Drug Delivery Device Market Size by Application
3.2.1 Global Active Transdermal Drug Delivery Device Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Active Transdermal Drug Delivery Device Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Active Transdermal Drug Delivery Device Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Active Transdermal Drug Delivery Device Market Size by Application
3.3.1 United States Active Transdermal Drug Delivery Device Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Active Transdermal Drug Delivery Device Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Active Transdermal Drug Delivery Device Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Active Transdermal Drug Delivery Device Competitor Landscape by Company
4.1 Global Active Transdermal Drug Delivery Device Market Size by Company
4.1.1 Top Global Active Transdermal Drug Delivery Device Manufacturers Ranked by Revenue (2021)
4.1.2 Global Active Transdermal Drug Delivery Device Revenue by Manufacturer (2017-2022)
4.1.3 Global Active Transdermal Drug Delivery Device Sales by Manufacturer (2017-2022)
4.1.4 Global Active Transdermal Drug Delivery Device Price by Manufacturer (2017-2022)
4.2 Global Active Transdermal Drug Delivery Device Concentration Ratio (CR)
4.2.1 Active Transdermal Drug Delivery Device Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Active Transdermal Drug Delivery Device in 2021
4.2.3 Global Active Transdermal Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Active Transdermal Drug Delivery Device Manufacturing Base Distribution, Product Type
4.3.1 Global Active Transdermal Drug Delivery Device Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Active Transdermal Drug Delivery Device Product Type
4.3.3 Date of International Manufacturers Enter into Active Transdermal Drug Delivery Device Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Active Transdermal Drug Delivery Device Market Size by Company
4.5.1 Top Active Transdermal Drug Delivery Device Players in United States, Ranked by Revenue (2021)
4.5.2 United States Active Transdermal Drug Delivery Device Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Active Transdermal Drug Delivery Device Sales by Players (2020, 2021 & 2022)
5 Global Active Transdermal Drug Delivery Device Market Size by Region
5.1 Global Active Transdermal Drug Delivery Device Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Active Transdermal Drug Delivery Device Market Size in Volume by Region (2017-2028)
5.2.1 Global Active Transdermal Drug Delivery Device Sales in Volume by Region: 2017-2022
5.2.2 Global Active Transdermal Drug Delivery Device Sales in Volume Forecast by Region (2023-2028)
5.3 Global Active Transdermal Drug Delivery Device Market Size in Value by Region (2017-2028)
5.3.1 Global Active Transdermal Drug Delivery Device Sales in Value by Region: 2017-2022
5.3.2 Global Active Transdermal Drug Delivery Device Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Active Transdermal Drug Delivery Device Market Size YoY Growth 2017-2028
6.1.2 North America Active Transdermal Drug Delivery Device Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Active Transdermal Drug Delivery Device Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Active Transdermal Drug Delivery Device Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Active Transdermal Drug Delivery Device Market Size YoY Growth 2017-2028
6.3.2 Europe Active Transdermal Drug Delivery Device Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Active Transdermal Drug Delivery Device Market Size YoY Growth 2017-2028
6.4.2 Latin America Active Transdermal Drug Delivery Device Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Active Transdermal Drug Delivery Device Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Active Transdermal Drug Delivery Device Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Novartis AG
7.1.1 Novartis AG Corporation Information
7.1.2 Novartis AG Description and Business Overview
7.1.3 Novartis AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Novartis AG Active Transdermal Drug Delivery Device Products Offered
7.1.5 Novartis AG Recent Development
7.2 Noven Pharmaceuticals, Inc.
7.2.1 Noven Pharmaceuticals, Inc. Corporation Information
7.2.2 Noven Pharmaceuticals, Inc. Description and Business Overview
7.2.3 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Noven Pharmaceuticals, Inc. Active Transdermal Drug Delivery Device Products Offered
7.2.5 Noven Pharmaceuticals, Inc. Recent Development
7.3 Transdermal Corp.
7.3.1 Transdermal Corp. Corporation Information
7.3.2 Transdermal Corp. Description and Business Overview
7.3.3 Transdermal Corp. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Transdermal Corp. Active Transdermal Drug Delivery Device Products Offered
7.3.5 Transdermal Corp. Recent Development
7.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
7.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporation Information
7.4.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Description and Business Overview
7.4.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Active Transdermal Drug Delivery Device Products Offered
7.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
7.5 Mylan N.V.
7.5.1 Mylan N.V. Corporation Information
7.5.2 Mylan N.V. Description and Business Overview
7.5.3 Mylan N.V. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Mylan N.V. Active Transdermal Drug Delivery Device Products Offered
7.5.5 Mylan N.V. Recent Development
7.6 3M
7.6.1 3M Corporation Information
7.6.2 3M Description and Business Overview
7.6.3 3M Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.6.4 3M Active Transdermal Drug Delivery Device Products Offered
7.6.5 3M Recent Development
7.7 Actavis, Inc.
7.7.1 Actavis, Inc. Corporation Information
7.7.2 Actavis, Inc. Description and Business Overview
7.7.3 Actavis, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Actavis, Inc. Active Transdermal Drug Delivery Device Products Offered
7.7.5 Actavis, Inc. Recent Development
7.8 Bayer AG
7.8.1 Bayer AG Corporation Information
7.8.2 Bayer AG Description and Business Overview
7.8.3 Bayer AG Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Bayer AG Active Transdermal Drug Delivery Device Products Offered
7.8.5 Bayer AG Recent Development
7.9 Boehringer Ingelheim GmbH
7.9.1 Boehringer Ingelheim GmbH Corporation Information
7.9.2 Boehringer Ingelheim GmbH Description and Business Overview
7.9.3 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Boehringer Ingelheim GmbH Active Transdermal Drug Delivery Device Products Offered
7.9.5 Boehringer Ingelheim GmbH Recent Development
7.10 Corium International, Inc.
7.10.1 Corium International, Inc. Corporation Information
7.10.2 Corium International, Inc. Description and Business Overview
7.10.3 Corium International, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Corium International, Inc. Active Transdermal Drug Delivery Device Products Offered
7.10.5 Corium International, Inc. Recent Development
7.11 Echo Therapeutics, Inc.
7.11.1 Echo Therapeutics, Inc. Corporation Information
7.11.2 Echo Therapeutics, Inc. Description and Business Overview
7.11.3 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Echo Therapeutics, Inc. Active Transdermal Drug Delivery Device Products Offered
7.11.5 Echo Therapeutics, Inc. Recent Development
7.12 GlaxoSmithKline plc
7.12.1 GlaxoSmithKline plc Corporation Information
7.12.2 GlaxoSmithKline plc Description and Business Overview
7.12.3 GlaxoSmithKline plc Active Transdermal Drug Delivery Device Sales, Revenue and Gross Margin (2017-2022)
7.12.4 GlaxoSmithKline plc Products Offered
7.12.5 GlaxoSmithKline plc Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Active Transdermal Drug Delivery Device Industry Chain Analysis
8.2 Active Transdermal Drug Delivery Device Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Active Transdermal Drug Delivery Device Distributors
8.3 Active Transdermal Drug Delivery Device Production Mode & Process
8.4 Active Transdermal Drug Delivery Device Sales and Marketing
8.4.1 Active Transdermal Drug Delivery Device Sales Channels
8.4.2 Active Transdermal Drug Delivery Device Distributors
8.5 Active Transdermal Drug Delivery Device Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer